| Document Date: 2014-06-09 18:06:42
Open Document File Size: 39,42 KBShare Result on Facebook
Company Winston Pharmaceuticals Winston / Winston Pharmaceuticals Inc. / / Currency USD / / Event FDA Phase / / Facility National Institute of Neurological Disorders / / IndustryTerm pain management products / pharmaceutical / nasal solution / civamide nasal solution / / MedicalCondition neuralgia / pain / facial neuropathic pain syndrome / inflammatory bowel disease / cancer / severe chronic pain / tension headache / Herpes Zoster / neuropathic disease / rheumatoid arthritis / Postherpetic Neuralgia / migraine / Trigeminal Nerve Postherpetic neuralgia / episodic cluster headache / / MedicalTreatment pain management / / Organization National Institute of Neurological Disorders and Stroke / National Institute of Health / U.S. Food and Drug Administration / / Person Joel E. Bernstein / / Position President and CEO / / Product nasal / Civamide / / ProvinceOrState Tennessee / Illinois / / URL www.winstonlabs.com / /
SocialTag |
Microsoft Word - REVISED SBIR Grant from the NIH to Investigate Treatment for Post-Herpetic Neuralgia of the Trigeminal Nerve